Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Evercure ScientificLikely | 1 | ₹1.2 L |
| 2 | Schedule 2 | MEDIGENE HEALTH CARE PRIVATE LIMITEDLikely | 1 | ₹4.1 L |
| 3 | Schedule 3 | MEDIGENE HEALTH CARE PRIVATE LIMITEDLikely | 1 | ₹6.1 L |
| 4 | Schedule 4 | ADSOLLikely | 1 | ₹6.0 L |
| 5 | Schedule 5 | NEXGEN ENTERPRISESLikely | 1 | ₹2.0 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
23 May 2025, 1:00 pmClosed
Everolimus coated drug eluting platinum chromium coronary stents assorted sizes
Everolimus eluting cobalt chromium stents with thin strut thickness 0.0032 and
Everolimus drug eluting cobalt cromium stent with thinstrut thickness 0.0032
Zotarolimus Drug Eluting Coronory Stent System with Core Wire Technology
Sirolimus Eluting Bioresorbable Vascular Scaffold BVS of PLLA Backbone
Sirolimus Eluting Coronary Side Branch Stent System with 65um
Sirolimus Eluting Coronary Tapered Stent System with hybrid cell design
Sirolimus Eluting Cobalt Chromium Coronary Stent system with UltraThin Struts
Everolimus Eluting Cobalt Chromium Coronary Stent system with UltraThin Struts
Sirolimus drug coated balloon with nanolute techonology low entery
Drug Eluting Coronory Balloon with Urea Paclitaxal coating assorted sizes
Dual Drug Polymer free Everolimus and Probucol eluting coronary stents system
Covered coronary Stent for use in life threatening coronary
Carotid Stent system with Closed Cell Design Assorted Sizes
Sirolimus drug eluting cobalt chromium stent with Ultrathin
Sirolimus eluting cobalt Chromium Coronary Stent with advance core wire
Sirolimus eluting cobalt Chromium Coronary Stent with shorter strut and bands
Sirolimus eluting cobalt Chromium Coronary Stent with Bioresorble
3T whole body safe MRI dual chamber pacemaker with deflectable
Antimirobial iodine impregnated incison site sterile plastic sheet Bid Number ( ) : GEM/2025/B/6137530 Dated : 02-05-2025 Bid Document 1/21
7736722
GEM/2025/B/6137530
Two Packet Bid
Everolimus coated drug eluting platinum chromium
Rajasthan; Jaipur
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3
50%
Exempted
23 May 2025
2 May 2025
23 May 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Everolimus coated drug eluting platinum chromium coronary stents assorted sizes | Everolimus coated drug eluting platinum chromium coronary stents assorted sizes | 5 | No | Everolimus Eluting Cobalt JAIPUR CITY (SOUTH) Chromium Stents With Thin | 21 |
| 2 | Everolimus eluting cobalt chromium stents with thin strut thickness 0.0032 and | Everolimus eluting cobalt chromium stents with thin strut thickness 0.0032 and fluorinated copolymer with multi link 8 multilayer pebax balloon mounted and mid marker for stent placement with a RBP of 18ATM assorted sizes till maximum of 38mm length | 10 | No | JAIPUR CITY (SOUTH) | 21 |
| 3 | Everolimus drug eluting cobalt cromium stent with thinstrut thickness 0.0032 | Everolimus drug eluting cobalt cromium stent with thinstrut thickness 0.0032 which is 4th generation coated with biocompatible fluorinated copolymer multi link 8 peak to valley 3 3 3 tailler and nonlinear link assorted sizes including 48mm lengths | 15 | No | JAIPUR CITY (SOUTH) | 21 |
| 4 | Zotarolimus Drug Eluting Coronory Stent System with Core Wire Technology | Zotarolimus Drug Eluting Coronory Stent System with Core Wire Technology Platinium Iridium Core and Continous Cobalt Chromium Sinusoid Technology Assorted Sizes | 15 | No | JAIPUR CITY (SOUTH) | 21 |
| 5 | Sirolimus Eluting Bioresorbable Vascular Scaffold BVS of PLLA Backbone | Sirolimus Eluting Bioresorbable Vascular Scaffold BVS of PLLA Backbone Bioresobable Polymer PDLLA Strut Thickness of 100 micron Hybrid Cell design with Triaxial RO markers. Assorted Sizes | 2 | No | Sirolimus Eluting Coronary JAIPUR CITY (SOUTH) Side Branch Stent System | 21 |
| 6 | Sirolimus Eluting Coronary Side Branch Stent System with 65um | Sirolimus Eluting Coronary Side Branch Stent System with 65um 0.065mm or 0.0026 strut thickness L605 Cobalt Chromium alloy and biodegradable PLLA plus PLGA polymer. Assorted Sizes | 3 | No | JAIPUR CITY (SOUTH) | 21 |
| 7 | Sirolimus Eluting Coronary Tapered Stent System with hybrid cell design | Sirolimus Eluting Coronary Tapered Stent System with hybrid cell design 65um 0.065mm or 0.002 strut thickness L605 Cobalt Chromium alloy and biodegradable PLLA plus PLGA polymer. Assorted Sizes | 3 | No | JAIPUR CITY (SOUTH) | 21 |
| 8 | Sirolimus Eluting Cobalt Chromium Coronary Stent system with UltraThin Struts | Sirolimus Eluting Cobalt Chromium Coronary Stent system with Ultra Thin Struts 60Microns across all diameters and length with a biodegradable polymer. Open cell design with long dual Z connectors. Assorted Sizes | 5 | No | JAIPUR CITY (SOUTH) | 21 |
| 9 | Everolimus Eluting Cobalt Chromium Coronary Stent system with UltraThin Struts | Everolimus Eluting Cobalt Chromium Coronary Stent system with Ultra Thin Struts 60Microns across all diameters and length with a biodegradable polymer. Open cell design with long dual Z connectors. Assorted Sizes | 5 | No | JAIPUR CITY (SOUTH) | 21 |
| 10 | Sirolimus drug coated balloon with nanolute techonology low entery | Sirolimus drug coated balloon with nanolute techonology low entery profile tip of 0.016 . Assorted Sizes | 2 | No | JAIPUR CITY (SOUTH) | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7736722.pdf
GEM_BID
adobe_scan_13-apr-2025_2025-04-13-10-48-14_c7630aa911a0285624e0c943b457c10a.pdf
BOQ
boq_item_sample_file_-_2025-04-13t103408-283_2025-04-13-10-48-14_86de46094bcc9f3de7b6375131548f8c.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .